Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zevalin and BEAM vs BEAM Alone in Relapsed NHL
NCT00463463Phase 3Unknown
- Sponsor
- Soroka University Medical Center
- Start
- Apr 2007
- Modality
- Recombinant Proteins and Enzymes, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of ibritumomab tiuxetan in non-Hodgkin lymphoma (NHL), sponsored by Soroka University Medical Center. Status: unknown.
02
Drugs
ibritumomab tiuxetan
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00463463.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00463463.